GABAB receptor

Last updated
gamma-aminobutyric acid (GABA) B receptor, 1
Identifiers
SymbolGABBR1
NCBI gene 2550
HGNC 4070
OMIM 603540
RefSeq NM_021905
UniProt Q9UBS5
Other data
Locus Chr. 6 p21.3
Search for
Structures Swiss-model
Domains InterPro
gamma-aminobutyric acid (GABA) B receptor, 2
Identifiers
SymbolGABBR2
Alt. symbolsGPR51
NCBI gene 9568
HGNC 4507
OMIM 607340
RefSeq NM_005458
UniProt O75899
Other data
Locus Chr. 9 q22.1-22.3
Search for
Structures Swiss-model
Domains InterPro

GABAB receptors (GABABR) are G-protein coupled receptors for gamma-aminobutyric acid (GABA). GABAB receptors are found in the central nervous system and the autonomic division of the peripheral nervous system. [1]

Contents

The receptors were first named in 1981 when their distribution in the CNS was determined, which was determined by Norman Bowery and his team using radioactively labelled baclofen. [2]

Functions

GABABRs stimulate the opening of K+ channels, specifically GIRKs, which brings the neuron closer to the equilibrium potential of K+. This reduces the frequency of action potentials which reduces neurotransmitter release.[ citation needed ] Thus GABAB receptors are usually considered as inhibitory receptors.

GABAB receptors can also function as an excitatory receptor and facilitate neurotransmitter release via increasing the activity of CaV2.3 channels. [3]

GABAB receptors usually reduces the activity of adenylyl cyclase and Ca2+ channels by using G-proteins with Gi/G0 α subunits. [4]

GABAB receptors are involved in behavioral actions of ethanol, [5] [6] gamma-hydroxybutyric acid (GHB), [7] and possibly in pain. [8] Recent research suggests that these receptors may play an important developmental role. [9]

Receptor dimer, inactive apo state, cartoon representation 6VJM GABAB Receptor dimer inactive.png
Receptor dimer, inactive apo state, cartoon representation

Structure

GABAB receptors are similar in structure to and in the same receptor family with metabotropic glutamate receptors. [10] There are two subunits of the receptor, GABAB1 and GABAB2, [11] and these appear to assemble as obligate heterodimers in neuronal membranes by linking up by their intracellular C termini. [10] In the mammalian brain, two predominant, differentially expressed isoforms of the GABAB1 are transcribed from the Gabbr1 gene, GABAB(1a) and GABAB(1b), which are conserved in different species including humans. [12] This might potentially offer more complexity in terms of the function due to different composition of the receptor. [12] Cryo-electron microscopy structures of the full length GABAB receptor in different conformational states from inactive apo to fully active have been obtained. Unlike Class A and B GPCRs, phospholipids bind within the transmembrane bundles and allosteric modulators bind at the interface of GABAB1 and GABAB2 subunits. [13] [14] [15] [16] [17] [18] [19]

Ligands

GABA Gamma-Aminobuttersaure - gamma-aminobutyric acid.svg
GABA
GHB 4-Hydroxybutansaure - 4-Hydroxybutanoic acid.svg
GHB
Lesogaberan Lesogaberan.svg
Lesogaberan

Agonists

CGP-7930 CGP-7930 chemical structure.svg
CGP-7930

Positive allosteric modulators

Phaclofen Phaclofen.svg
Phaclofen
SCH-50911 SCH-50911.svg
SCH-50911

Antagonists

See also

References

  1. Hyland NP, Cryan JF (2010). "A Gut Feeling about GABA: Focus on GABA(B) Receptors". Frontiers in Pharmacology. 1: 124. doi: 10.3389/fphar.2010.00124 . PMC   3153004 . PMID   21833169.
  2. Hill DR, Bowery NG (March 1981). "3H-baclofen and 3H-GABA bind to bicuculline-insensitive GABA B sites in rat brain". Nature. 290 (5802): 149–52. Bibcode:1981Natur.290..149H. doi:10.1038/290149a0. PMID   6259535. S2CID   4335907.
  3. Zhang, Juen; Tan, Lubin; Ren, Yuqi; Liang, Jingwen; Lin, Rui; Feng, Qiru; Zhou, Jingfeng; Hu, Fei; Ren, Jing; Wei, Chao; Yu, Tao; Zhuang, Yinghua; Bettler, Bernhard; Wang, Fengchao; Luo, Minmin (July 2016). "Presynaptic Excitation via GABA B Receptors in Habenula Cholinergic Neurons Regulates Fear Memory Expression". Cell. 166 (3): 716–728. doi: 10.1016/j.cell.2016.06.026 .
  4. Rang HP, Dale MM, Ritter JM, Flower RJ, Henderson G (2016). Rang and Dale's Pharmacology (8th ed.). Elsevier, Churchill Livingstone. p. 462. ISBN   978-0-7020-5362-7. OCLC   903234097.
  5. Dzitoyeva S, Dimitrijevic N, Manev H (April 2003). "Gamma-aminobutyric acid B receptor 1 mediates behavior-impairing actions of alcohol in Drosophila: adult RNA interference and pharmacological evidence". Proceedings of the National Academy of Sciences of the United States of America. 100 (9): 5485–90. Bibcode:2003PNAS..100.5485D. doi: 10.1073/pnas.0830111100 . PMC   154371 . PMID   12692303.
  6. Ariwodola OJ, Weiner JL (November 2004). "Ethanol potentiation of GABAergic synaptic transmission may be self-limiting: role of presynaptic GABA(B) receptors". The Journal of Neuroscience. 24 (47): 10679–86. doi: 10.1523/JNEUROSCI.1768-04.2004 . PMC   6730127 . PMID   15564584.
  7. Dimitrijevic N, Dzitoyeva S, Satta R, Imbesi M, Yildiz S, Manev H (September 2005). "Drosophila GABA(B) receptors are involved in behavioral effects of gamma-hydroxybutyric acid (GHB)". European Journal of Pharmacology. 519 (3): 246–52. doi:10.1016/j.ejphar.2005.07.016. PMID   16129424.
  8. Manev H, Dimitrijevic N (May 2004). "Drosophila model for in vivo pharmacological analgesia research". European Journal of Pharmacology. 491 (2–3): 207–8. doi:10.1016/j.ejphar.2004.03.030. PMID   15140638.
  9. Dzitoyeva S, Gutnov A, Imbesi M, Dimitrijevic N, Manev H (August 2005). "Developmental role of GABAB(1) receptors in Drosophila". Brain Research. Developmental Brain Research. 158 (1–2): 111–4. doi:10.1016/j.devbrainres.2005.06.005. PMID   16054235.
  10. 1 2 MRC (Medical Research Council). 2003. Glutamate receptors: Structures and functions. University of Brisotol Centre for Synaptic Plasticity.
  11. Purves D, Augustine GJ, Fitzpatrick D, Katz LC, LaMantia AS, McNamara JO, Williams SM (2001). "7. Neurotransmitter Receptors and Their Effects". Neuroscience (Second ed.). Sinauer Associates, Inc.
  12. 1 2 Kaupmann K, Huggel K, Heid J, Flor PJ, Bischoff S, Mickel SJ, et al. (March 1997). "Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors" . Nature. 386 (6622): 239–46. Bibcode:1997Natur.386..239K. doi:10.1038/386239a0. PMID   9069281. S2CID   4345443.
  13. Shaye H, Stauch B, Gati C, Cherezov V (May 2021). "Molecular mechanisms of metabotropic GABAB receptor function". Science Advances. 7 (22): eabg3362. Bibcode:2021SciA....7.3362S. doi:10.1126/sciadv.abg3362. PMC   8163086 . PMID   34049877.
  14. Shaye H, Ishchenko A, Lam JH, Han GW, Xue L, Rondard P, et al. (August 2020). "Structural basis of the activation of a metabotropic GABA receptor". Nature. 584 (7820): 298–303. Bibcode:2020Natur.584..298S. doi:10.1038/s41586-020-2408-4. PMC   8020835 . PMID   32555460.
  15. Papasergi-Scott MM, Robertson MJ, Seven AB, Panova O, Mathiesen JM, Skiniotis G (June 2020). "Structures of metabotropic GABAB receptor". Nature. 584 (7820): 310–314. Bibcode:2020Natur.584..310P. doi:10.1038/s41586-020-2469-4. PMC   7429364 . PMID   32580208.
  16. Mao C, Shen C, Li C, Shen DD, Xu C, Zhang S, et al. (June 2020). "B receptor". Cell Research. 30 (7): 564–573. doi:10.1038/s41422-020-0350-5. PMC   7343782 . PMID   32494023. S2CID   219183617.
  17. Park J, Fu Z, Frangaj A, Liu J, Mosyak L, Shen T, et al. (June 2020). "B receptor in an inactive state". Nature. 584 (7820): 304–309. doi:10.1038/s41586-020-2452-0. PMC   7725281 . PMID   32581365. S2CID   220050861.
  18. Kim Y, Jeong E, Jeong JH, Kim Y, Cho Y (November 2020). "Structural Basis for Activation of the Heterodimeric GABAB Receptor". Journal of Molecular Biology. 432 (22): 5966–5984. doi:10.1016/j.jmb.2020.09.023. PMID   33058878. S2CID   222841520.
  19. Shen C, Mao C, Xu C, Jin N, Zhang H, Shen DD, et al. (June 2021). "Structural basis of GABAB receptor-Gi protein coupling". Nature. 594 (7864): 594–598. Bibcode:2021Natur.594..594S. doi:10.1038/s41586-021-03507-1. PMC   8222003 . PMID   33911284.
  20. Urwyler S, Mosbacher J, Lingenhoehl K, Heid J, Hofstetter K, Froestl W, et al. (November 2001). "Positive allosteric modulation of native and recombinant gamma-aminobutyric acid(B) receptors by 2,6-Di-tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) and its aldehyde analog CGP13501". Molecular Pharmacology. 60 (5): 963–71. doi:10.1124/mol.60.5.963. PMID   11641424. Archived from the original on 2008-10-11. Retrieved 2009-04-12.
  21. Adams CL, Lawrence AJ (2007). "CGP7930: a positive allosteric modulator of the GABAB receptor". CNS Drug Reviews. 13 (3): 308–16. doi:10.1111/j.1527-3458.2007.00021.x. PMC   6494120 . PMID   17894647.
  22. Paterson NE, Vlachou S, Guery S, Kaupmann K, Froestl W, Markou A (July 2008). "Positive modulation of GABA(B) receptors decreased nicotine self-administration and counteracted nicotine-induced enhancement of brain reward function in rats". The Journal of Pharmacology and Experimental Therapeutics. 326 (1): 306–14. doi:10.1124/jpet.108.139204. PMC   2574924 . PMID   18445779.
  23. Urwyler S, Pozza MF, Lingenhoehl K, Mosbacher J, Lampert C, Froestl W, et al. (October 2003). "N,N'-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine (GS39783) and structurally related compounds: novel allosteric enhancers of gamma-aminobutyric acidB receptor function". The Journal of Pharmacology and Experimental Therapeutics. 307 (1): 322–30. doi:10.1124/jpet.103.053074. PMID   12954816. S2CID   26152839.
  24. Giotti A, Luzzi S, Spagnesi S, Zilletti L (August 1983). "Homotaurine: a GABAB antagonist in guinea-pig ileum". British Journal of Pharmacology. 79 (4): 855–62. doi:10.1111/j.1476-5381.1983.tb10529.x. PMC   2044932 . PMID   6652358.
  25. Kimura T, Saunders PA, Kim HS, Rheu HM, Oh KW, Ho IK (January 1994). "Interactions of ginsenosides with ligand-bindings of GABA(A) and GABA(B) receptors". General Pharmacology. 25 (1): 193–9. doi:10.1016/0306-3623(94)90032-9. PMID   8026706.
  26. Froestl W, Gallagher M, Jenkins H, Madrid A, Melcher T, Teichman S, et al. (October 2004). "SGS742: the first GABA(B) receptor antagonist in clinical trials". Biochemical Pharmacology. 68 (8): 1479–87. doi:10.1016/j.bcp.2004.07.030. PMID   15451390.
  27. Bullock R (January 2005). "SGS-742 Novartis". Current Opinion in Investigational Drugs. 6 (1): 108–13. PMID   15675610.